Moneycontrol
HomeNewsBusinessMarketsTop 5 possible outcomes for investors post COVID-19 outbreak: EA Sundaram
Trending Topics

Top 5 possible outcomes for investors post COVID-19 outbreak: EA Sundaram

There is no doubt that the COVID-19 would be a major disruptor for several businesses. Estimates vary widely about the extent of the damage but suffice it to say that the damage would be extremely large.

April 24, 2020 / 10:29 IST
Story continues below Advertisement

There is no doubt that the COVID-19 would be a major disruptor for several businesses. Estimates vary widely regarding the extent of damage, but it is safe to say that the damage would be extremely large, EA Sundaram, Executive Director & CIO- Equities- o3 Capital, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Story continues below Advertisement

Q) What is your take on the financial stimulus offered so far by the RBI and government?

A) We believe that the RBI has done what it could. Reverse Repo rate has been reduced by 0.25 percent, there is an Rs 50,000 crore fund for NBFCs, plus a Rs 10,000 crore fund for housing finance companies.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show